- Home
- STUB vs RGEN Comparison
STUB vs RGEN Comparison
Compare STUB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STUB
- RGEN
- Stock Information
- Founded
- STUB 2000
- RGEN 1981
- Country
- STUB United States
- RGEN United States
- Employees
- STUB N/A
- RGEN N/A
- Industry
- STUB Services-Misc. Amusement & Recreation
- RGEN Medical/Dental Instruments
- Sector
- STUB Consumer Discretionary
- RGEN Health Care
- Exchange
- STUB Nasdaq
- RGEN Nasdaq
- Market Cap
- STUB 6.4B
- RGEN 6.5B
- IPO Year
- STUB 2025
- RGEN N/A
- Fundamental
- Price
- STUB $20.19
- RGEN $164.90
- Analyst Decision
- STUB Buy
- RGEN Buy
- Analyst Count
- STUB 10
- RGEN 11
- Target Price
- STUB $27.78
- RGEN $167.90
- AVG Volume (30 Days)
- STUB 3.7M
- RGEN 1.1M
- Earning Date
- STUB 11-26-2025
- RGEN 10-28-2025
- Dividend Yield
- STUB N/A
- RGEN N/A
- EPS Growth
- STUB N/A
- RGEN N/A
- EPS
- STUB N/A
- RGEN N/A
- Revenue
- STUB $1,795,096,000.00
- RGEN $673,956,000.00
- Revenue This Year
- STUB N/A
- RGEN $16.77
- Revenue Next Year
- STUB N/A
- RGEN $13.79
- P/E Ratio
- STUB N/A
- RGEN N/A
- Revenue Growth
- STUB 18.61
- RGEN 8.73
- 52 Week Low
- STUB $16.11
- RGEN $102.97
- 52 Week High
- STUB $27.89
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- STUB N/A
- RGEN 71.86
- Support Level
- STUB N/A
- RGEN $155.74
- Resistance Level
- STUB N/A
- RGEN $169.87
- Average True Range (ATR)
- STUB 0.00
- RGEN 5.46
- MACD
- STUB 0.00
- RGEN 0.93
- Stochastic Oscillator
- STUB 0.00
- RGEN 81.17
About STUB StubHub Holdings Inc. Class A Common Stock
Stubhub Holdings Inc is an online marketplace for secondary ticket buy and selling.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.